基于传感器的电子监测改善儿童哮喘控制:一项随机对照试验
该随机对照试验将照顾者与儿童配对随机分配至接受吸入器传感器电子监测组或对照组,评估哮喘控制测试评分与医疗保健使用情况。干预组哮喘控制测试评分改善显著大于对照组(差值2.2,P<.01),但急诊就诊和住院调整率也显著更高。结论提示传感器监测配合临床反馈可能改善哮喘控制和照顾者生活质量,但医疗使用增加需进一步优化。
要点
- 传感器监测组哮喘控制测试评分较对照组多提高2.2分(P<.01)。
- 干预组急诊就诊率是对照组的2.2倍,住院率是3.4倍(均P<.01)。
- 照顾者生活质量在干预组有改善趋势但差异未达统计学显著(P=.1)。
核心结论
- 基于传感器的吸入器监测配合临床反馈可能改善不同儿科人群的哮喘控制和照顾者生活质量。
- 干预组医疗保健使用率高于对照组,提示需进一步优化干预方案。
研究设计与样本
- 随机对照试验,照顾者与儿童配对随机分配至对照组(n=127)或干预组(n=125)。
- 干预组接受吸入器传感器以实现照顾者和临床医生对药物的电子监测。
- 采用多水平模型估计从基线的调整变化。
主要发现
- 终点时干预组哮喘控制测试评分从19.1(SE=0.3)升至21.8(SE=0.4),对照组从19.4(SE=0.3)升至19.9(SE=0.4),干预-对照差值2.2(SE=0.6,P<.01)。
- 终点时干预组急诊就诊调整率显著高于对照组(发生率比=2.2,SE=0.5,P<.01)。
- 终点时干预组住院调整率显著高于对照组(发生率比=3.4,SE=1.4,P<.01)。
- 终点时干预组照顾者生活质量高于对照组,差值0.3(SE=0.2,P=.1)。
关键数值与推荐
- 哮喘控制测试评分≥19提示哮喘控制。
- 终点时干预组哮喘控制测试平均分21.8(SE=0.4),对照组19.9(SE=0.4)。
临床怎么用
- 可考虑使用吸入器传感器电子监测结合临床反馈以改善儿童哮喘控制和照顾者生活质量。
- 需警惕干预可能伴随更高的急诊和住院使用率,应进一步优化监测与反馈策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although sensor-based monitoring of daily inhaled corticosteroids (ICSs) and short-acting β-agonist medications may improve asthma outcomes, the effectiveness of these interventions in diverse pediatric populations remains unclear. METHODS: Caregiver and child dyads were randomly assigned to receive inhaler sensors that allowed for caregiver and clinician electronic monitoring of medications. End points included Asthma Control Test scores (≥19 indicated asthma control) and asthma health care use. Caregiver quality of life (QoL) and child ICS adherence were also assessed. Multilevel models were used to estimate adjusted changes from baseline. RESULTS: Dyads were assigned to the control (n = 127) or intervention (n = 125) arms. At the end line, the mean Asthma Control Test score increased from 19.1 (SE = 0.3) to 21.8 (SE = 0.4) among the intervention and from 19.4 (SE = 0.3) to 19.9 (SE = 0.4) among the control (Δintervention-control = 2.2; SE = 0.6; P < .01). Adjusted rates of emergency department visits and hospitalizations among the intervention were significantly greater (incidence rate ratioemergency department = 2.2; SE = 0.5; P < .01; incidence rate ratiohospital = 3.4; SE = 1.4; P < .01) at endline than the control. Caregiver QoL was greater among the intervention at the endline (Δintervention-control = 0.3; SE = 0.2; P = .1) than the control. CONCLUSIONS: Findings suggest that sensor-based inhaler monitoring with clinical feedback may improve asthma control and caregiver QoL within diverse populations. Higher health care use was observed among the intervention participants relative to the control, indicating further refinement is warranted.
引用
- Gupta RS, Fierstein JL, Boon KL, et al. Sensor-Based Electronic Monitoring for Asthma: A Randomized Controlled Trial. Pediatrics. 2021. PMID: 33386336. doi:10.1542/peds.2020-1330
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。